CVI 2020 Webinar Series 

Coronary CTO PCI: Still the Last Frontier?

August 13, 2020 – August 13, 2021

This activity has been designed to meet the educational needs of cardiologists, surgeons, internists, trainees, investigators, and allied health care workers who participate in the care of patients with coronary, peripheral, and structural cardiovascular diseases.

The goal of this activity is to provide participants with knowledge on how to treat patients with coronary artery disease, peripheral vascular disease, and valvular, structural heart and arrhythmic heart disease.


  • Describe contemporary antegrade and retrograde techniques for recanalization of coronary CTOs
  • Discuss contemporary success and complication rate with CTO PCI
  • List equipment necessary for CTO PCI
  • Define strategies for preventing and treating complications of CTO PCI


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutions and Cardiovascular Innovations Foundation. The CMEsolutions is accredited by the ACCME to provide continuing medical education for physicians.

The CMEsolutions designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Start Date: August 13, 2020   End Date: August 13, 2021

  • View webinar
  • At the end of the webinar, login to:
  • Complete the Evaluation/Credit Request Form
  • Download or Print Credit Statement. No credit requests will be accepted after August 13, 2021


Khaldoon Alaswad, MD
Director, Cardiac Catheterization Lab, Henry Ford Hospital
Detroit, MI
Khaldoon Alaswad has no relevant financial relationships to disclose.

Emmanouil S. Brilakis, MD, PhD
Director, Center for Complex Coronary Interventions, Minneapolis Heart institute
Minneapolis, MN
Emmanouil Brilakis has disclosed the following relevant financial relationships: Abbott Vascular, Boston Scientific, CS, GE Healthcare-Consultant, Speaker's Bureau; Amgen, Infra Redx, Teleflex-Speaker Bureau; Regeneron, Siemens Healthineers-Research Grant, Speaker's Bureau; Elsevier-Consultant

Anbukarasi Maran, MD
Associate Professor, Medical University of South Carolina
Charleston, SC
Anbukarasi Maran has disclosed the following relevant financial relationships: Philips, Medtronic, Boston Scientific- Consultant, Speaker’s Bureau

Paul Poommipanit, MD
Clinical Professor, University Hospitals Cleveland
Parma, OH
Paul Poommipanit has disclosed the following relevant financial relationships: Asahi Intecc, Inc., Abbott Vascular-Consultant

Jason Wollmuth, MD
Interventional Cardiologist, Providence Heart and Vascular Institute
Providence, RI
Jason Wollmuth has disclosed the following relevant financial relationships: Abbott St. Jude Medical, Abiomed, Asahi Intecc, Boston Scientific, Philips- Consultant, Speaker’s Bureau

Planner Disclosures

Kelly Desatnik
Program Director, Cardiovascular Innovations Foundation
Denver, CO
Nothing to Disclose

Joel Brill, MD, FACP
Professor of Medicine, University of Arizona and Midwestern University
Scottsdale, AZ
Nothing to Disclose

Christopher King, BS
Managing Partner, CMEsolutions
Camden, ME
Nothing to Disclose

Off-label Use

This activitymay contain discussion of unlabeled and/or investigational uses of agents not approved by the FDA.  Please consult the prescribing information for each product.

Commercial Support

Commercial Support for this educational activity will be provided by the following:

  • Boston Scientific
  • Medtronic
  • Philips

Privacy Policy

CMEsolutions Privacy and Confidentiality Policy:
CMEsolutions can be contacted at .

 complete evaluation/credit request